KR910700347A - 프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스 - Google Patents

프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스 Download PDF

Info

Publication number
KR910700347A
KR910700347A KR1019900701934A KR900701934A KR910700347A KR 910700347 A KR910700347 A KR 910700347A KR 1019900701934 A KR1019900701934 A KR 1019900701934A KR 900701934 A KR900701934 A KR 900701934A KR 910700347 A KR910700347 A KR 910700347A
Authority
KR
South Korea
Prior art keywords
nucleotide sequence
gene
recombinant
virus
abipoxvirus
Prior art date
Application number
KR1019900701934A
Other languages
English (en)
Other versions
KR940001265B1 (ko
Inventor
료헤이 오가와
노보루 야나기다
사끼꼬 사에끼
세쓰꼬 오오까와
Original Assignee
다끼시와 다께시
닛뽕 제온 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다끼시와 다께시, 닛뽕 제온 가부시끼가이샤 filed Critical 다끼시와 다께시
Publication of KR910700347A publication Critical patent/KR910700347A/ko
Application granted granted Critical
Publication of KR940001265B1 publication Critical patent/KR940001265B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24041Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18111Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

내용 없음.

Description

프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1,2,3도는 본 발명에 따라 프로모터 활성을 갖는 단편 14-6, 49-22, 41-3 및 37-1의 뉴클레오티드 서열을 나타낸다.

Claims (12)

  1. 프로모터 활성을 갖는 제1,2,3 또는 4도에 나타낸 뉴클레오티드 서열의 일부 또는 전부를 함유하는 뉴클레오티드 서열.
  2. 제1항에 있어서, 뉴클레오티드 서열이 제4도에 나타낸 뉴클레오티드 서열중 404~515 뉴클레오티드의 일부 또는 전부를 함유하는 것인 뉴클레오티드 서열.
  3. 제2항에 있어서, 뉴클레오티드 서열이 제4도에 나타낸 뉴클레오티드 서열중 489~505 뉴클레오티드의 일부 또는 전부를 함유하는 것인 뉴클레오티드 서열.
  4. 제1항 내지 3항중 어느 한 항의 뉴클레오티드 서열, 및 상기 뉴클레오티드 서열 지배하에 있는, 폴리펩티드를 코팅하는 외인성 유전자를 함유하는 키메라9chimera) 유전자.
  5. 제4항에 있어서, 상기 외인성 유전자가 뉴카슬병(New-castle disease) 비루스 항원을 코딩하는 유전자인 키메라 유전자.
  6. 제5항에 있어서, 상기 뉴카슬병 비루스 항원이 헤마글루미닌 뉴라미니다제(hemagglutinin neuraminidase)인 키메라 유전자.
  7. 제4항 내지 6항중 어느 한 항에 따른 키메라 유전자를 함유하며 에스케리키아콜리(Escherichia coli)내에서 증식할 수 있는 플라스미드.
  8. 제7항에 있어서, 상기 키메라 유전자가 아비폭스비루스(Avipoxvirus)의 증식에 비-필수적인 게놈 영역에서 유래된 뉴클레오티드 서열내에 삽입된 플라스미드.
  9. 아비폭스비루스의 증식에 비-필수적인 게놈 영역내에 삽입된, 제4항 내지 6항중 어느 한 항에 따른 키메라 유전자를 함유하는 재조합 아비폭스비루스.
  10. 제9항에 있어서, 상기 아비폭스비루스가 파울폭스비루스(fowlpoxvirus)인 재조합 아비폭스비루스.
  11. 프로모터 지배하에 있지 않은 마커 유전자를 함유하는 플라스미드의 마키 유전자의 상류에 비루스-유래 DNA 단면을 삽입하고, 상기 플라스미드를 사용하여 재조합 비루스를 제작하고, 재조합 비루스로 마커 유전자-삭제 세포를 감염시키고, 마키 유전자가 발현되는 세포를 선택하고, 및 삽입된 DNA 단면의 뉴클레오티드 서열을 분석함을 특징으로 하는, 프로모터 활성을 갖는 뉴클레오티드 서열의 선택방법.
  12. 제10항에 있어서, 상기 마커 유전자가 1acz 유전자인 프로모터 활성을 갖는 뉴클레오티드 서열의 선택방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900701934A 1988-12-29 1989-12-28 프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스 KR940001265B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP33560588 1988-12-29
JP63-335605 1988-12-29
JP1-76025 1989-03-28
JP7602589 1989-03-28
PCT/JP1989/001330 WO1990007581A1 (fr) 1988-12-29 1989-12-28 Promoteur, plasmide le contenant, et avipoxvirus de recombinaison

Publications (2)

Publication Number Publication Date
KR910700347A true KR910700347A (ko) 1991-03-14
KR940001265B1 KR940001265B1 (ko) 1994-02-18

Family

ID=26417177

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900701934A KR940001265B1 (ko) 1988-12-29 1989-12-28 프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스

Country Status (4)

Country Link
EP (1) EP0419666A4 (ko)
KR (1) KR940001265B1 (ko)
AU (1) AU623476B2 (ko)
WO (1) WO1990007581A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0353851B1 (en) * 1988-06-24 1994-01-19 Btg International Limited Fowlpox virus non-essential regions
JP2781605B2 (ja) * 1989-06-22 1998-07-30 日本ゼオン株式会社 組み換えアビポックスウイルス
KR930701588A (ko) * 1990-07-02 1993-06-12 스튜어트 알. 슈터 재조합 구두 바이러스 백신
BE1004877A3 (fr) * 1991-05-27 1993-02-16 Solvay Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61170393A (ja) * 1985-01-21 1986-08-01 Nippon Zeon Co Ltd 組換え体ベクタ−及びその製造法
JPS61271990A (ja) * 1985-05-27 1986-12-02 Agency Of Ind Science & Technol 改造ジヒドロ葉酸還元酵素遺伝子を含む特定dna配列
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
DE3853088T2 (de) * 1987-03-27 1995-10-19 Nippon Zeon Co Rekombinantes Avipoxvirus.
CA1340203C (en) * 1987-09-16 1998-12-15 Noboru Yanagida Recombinant apivoxvirus
EP0353851B1 (en) * 1988-06-24 1994-01-19 Btg International Limited Fowlpox virus non-essential regions
CA2001001A1 (en) * 1988-10-21 1990-04-21 Matthew M. Binns Fowlpox virus promoter

Also Published As

Publication number Publication date
EP0419666A1 (en) 1991-04-03
WO1990007581A1 (fr) 1990-07-12
EP0419666A4 (en) 1991-05-15
KR940001265B1 (ko) 1994-02-18
AU623476B2 (en) 1992-05-14
AU4824090A (en) 1990-08-01

Similar Documents

Publication Publication Date Title
Britton et al. Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus
ATE142700T1 (de) Genetische manipulationen mit von rna-viren abgeleiteten sequenzen enthaltendem rekombinantem dna
EP0414689A4 (en) Pox virus vectors
MX9700817A (es) Secuencia viral de nucleotidos de "vr-2332" y metodos de uso.
ES2173867T3 (es) Uso de nucleotidos externos a la muestra en clonacion genetica.
NL300300I1 (nl) Expressiesystemen voor recombinante RNA-virussen met een negatieve styreng en vaccins.
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
WO2000003030A3 (en) Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
DE69131903T2 (de) Klonierung hühner-anaemia-virus-dna
KR910700347A (ko) 프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스
DK384185D0 (da) Ekspressionsvektorer
DK0651806T3 (da) Vacciner imod katteimmundeficiensvirus (FIV)
ES2061850T3 (es) Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna.
KR910001061A (ko) 재조합 아비폭스비루스
US5332676A (en) Avipox virus promoter
McCoy et al. Nucleotide and amino acid sequence analysis of the 100K protein of a serotype 3 porcine adenovirus
Smirnov et al. Synthesis and expression of the DNA fragment coding for antigenic determinant of the protein of hepatitis virus B surface antigen.
KR950005988A (ko) 곤충세포를 이용한 인간 적혈구 성장촉진인자의 제조
KR950003446A (ko) 돌연변이체 aox2 프로모터, 이를 보유한 벡터, 형질 전환체, 및 이종 단백질의 제조방법
Boyle et al. Pox virus vaccine
KR960014344A (ko) 담배 모자이크 바이러스 토마토종(TMV-t)의 외피유전자
KR950005840A (ko) 씨(C)형 간염바이러스의 2비 프로테아제(2B protease) 및 그의 제조방법
KR830010193A (ko) 바실러스 클로닝 매개체, 재결합 dna분자 그것들과 함께 변형된 간균 숙주 그리고 이종(異知) dna배열의 표현 방법과 그것으로 이루어진 폴리펩타이드의 생성방법
KR950005994A (ko) 곤충세포를 이용한 씨(C)형 간염바이러스의 핵(Core22) 단백질의 제조
KR930000127A (ko) 비(非)a 비(非)b형 간염 진단방법 및 백신

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee